Infectious diseases (London, England)
Empirical piperacillin/tazobactam vs carbapenems to treat bloodstream infections due to ESBL enterobacterales: a propensity score-matched observational study conducted in an emergency department in Northern Italy.
Nicolò Capsoni, Marco Bettina, Beatrice Bellone, Ilaria Emanuela Bossi, Lisa Cantù, Marta Rossmann, Marida Scarnera, Irene Serrai, Silvia Vergani, Daniele Privitera, Davide Paolo Bernasconi, Massimo Puoti, Marco Merli, Filippo Galbiati, Giorgio Costantino
Published: 202510.1080/23744235.2025.2600010
Abstract
BACKGROUND: Piperacillin/tazobactam is frequently used empirically in patients subsequently diagnosed with bloodstream infections (BSIs) due to extended-spectrum β-lactamase (ESBL) Enterobacterales, yet its effectiveness remains uncertain. OBJECTIVE:…
Preview only. Read the full abstract at the source